drug
as of 2026-07-01NMDAE plus AIFA
at a glance
small molecule
Pre-approval / investigational in the US
Developed by China Medical University Hospital
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
NCT05240976Phase 2Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
NCT04917302Phase 2Recruiting
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication